You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 138 No. 3, March 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Evidence-Based Dermatology: Research Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Dermatologic Disorders
 •Hypersensitivity
 •Dermatologic Disorders, Other
 •Dermatology, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prevention of Atopic Eczema: A Dream Not So Far Away?

Hywel C. Williams, PhD

Arch Dermatol. 2002;138:391-392.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial
Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E
Lancet. 2001;357:1076–1079

Probiotics are cultures of potentially beneficial bacteria of microflora of the healthy gut. Previous epidemiological studies that have suggested that there is an inverse relationship between infections and atopic disease. Kalliomaki and colleagues proposed that specific microbes in the commensal microflora of the gut during early life might be more important than sporadic infections in the prevention of atopic disease. They argue that commensal gastrointestinal microbes are the earliest and biggest stimulus for the development of gut-associated lymphoid tissue that may counter the skewed TH2 helper cell lymphocyte response that is characteristic of atopic disease. The objective of this double-blind, placebo-controlled, randomized parallel group study was to see whether atopic disease could be prevented in infants at high risk of . . . [Full Text of this Article]

Editor's Comment

Department of Dermatoepidemiology
Centre of Evidence-Based Dermatology
Queen's Medical Centre
Nottingham NG7 2UH, England
(e-mail: hywel.williams@nottingham.ac.uk)



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.